ClinicalTrials.Veeva

Menu

Noninvasive Brain Stimulation for Stroke (NIBSstroke)

U

University Hospital of Mont-Godinne

Status

Suspended

Conditions

Stroke

Treatments

Device: tdcs (ELDITH, Neuroconn, Ilmenau, Germany)

Study type

Interventional

Funder types

Other

Identifiers

NCT01503073
B03920073136

Details and patient eligibility

About

Noninvasive brain stimulations will be used in acute and chronic stroke patients to improve a variety of functions.

Full description

Noninvasive brain stimulations (NIBS) will be used in acute and chronic stroke patients to improve a variety of functions such as motor functions, cognitive functions, ...

NIBS will be applied in a placebo-controlled, double-blind, randomised fashion. Behavioural data will be collected before and after NIBS, as well as brain functional imaging data.

Enrollment

200 estimated patients

Sex

All

Ages

18 to 90 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • stroke with at least slight deficit

Exclusion criteria

  • epilepsy
  • contraindication to tDCS and/or to fMRI
  • presence of metal in the head
  • unability to understand / complete behavioural tasks
  • chronic intake of alcohol or recreative drugs
  • major health condition
  • presence of pacemaker
  • pregnancy

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Quadruple Blind

200 participants in 2 patient groups

Real stimulation
Active Comparator group
Description:
real NIBS
Treatment:
Device: tdcs (ELDITH, Neuroconn, Ilmenau, Germany)
Sham stimulation
Sham Comparator group
Description:
sham NIBS
Treatment:
Device: tdcs (ELDITH, Neuroconn, Ilmenau, Germany)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems